Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1

Journal of the American College of Cardiology

Volumn 65, Issue 3, 2015, Pages 225-232

  Friberg, Leif ^a,b   Skeppholm, Mika ^a,b   Terént, Andreas ^c  

^a Sweden Karolinska Institutet Department of Clinical Sciences Danderyd Hospital Stressrehab FoU Danderyd   (United States)

^b DANDERYD HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

epidemiology; oral anticoagulation; stroke

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULATION; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE ASSESSMENT; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SWEDEN; TRANSIENT ISCHEMIC ATTACK; AGED; ATRIAL FIBRILLATION; REGISTER; STROKE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; SWEDEN; WARFARIN;

EID: 84921325726     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.10.052     Document Type: Article

References (32)

1. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation J Am Coll Cardiol 48 2006 854 906
2. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
3. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
4. J.S. Healey, R. Parkash, T. Pollak, T. Tsang, and P. Dorian Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations Can J Cardiol 27 2011 31 37
5. J. You Antithrombotic therapy for atrial fibrillation - antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2012 e3531S e3575S
6. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
7. G.Y. Lip, L. Frison, J.L. Halperin, and D.A. Lane Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort Stroke 41 2010 2731 2738
8. J.B. Olesen, G.Y. Lip, and M.L. Hansen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
9. D. Poli, G.Y. Lip, E. Antonucci, E. Grifoni, and D. Lane Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population J Cardiovasc Electrophysiol 22 2011 25 30
10. Y. Guo, S. Apostolakis, and A.D. Blann Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation Int J Cardiol 168 2013 904 909
11. L. Friberg, M. Rosenqvist, and G.Y. Lip Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort Study Eur Heart J 33 2012 1500 1510
12. 2 score of 1 who are unlikely to benefit from oral anticoagulant therapy Eur Heart J 34 2013 170 176
13. S. Apostolakis, M. Zubaid, and W.A. Rashed Gulf Survey of Atrial Fibrillation Events I. Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: the Gulf Safe Registry Int J Cardiol 168 2013 1644 1646
14. D.E. Singer, Y. Chang, and M.C. Fang The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 2009 297 305
15. J.B. Olesen, G.Y. Lip, and J. Lindhardsen Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study Thromb Haemost 106 2011 739 749
16. L. Friberg, M. Rosenqvist, and G.Y. Lip Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish Atrial Fibrillation Cohort Study Circulation 125 2012 2298 2307
17. The Swedish Board of Health and Welfare. Quality of coding in the national Swedish Patient register, hospital care 2008. Only available in Swedish [Socialstyrelsen. Kodningskvalitet i patientsregistret, slutenvård 2008]. Socialstyrelsen 2010. Available at: http://www.socialstyrelsen.se/publikationer2010/2010-6-27. Accessed November 7, 2014.
18. J.G. Smith, P.G. Platonov, B. Hedblad, G. Engstrom, and O. Melander Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity Eur J Epidemiol 25 2010 95 102
19. J.F. Ludvigsson, E. Andersson, and A. Ekbom External review and validation of the Swedish national inpatient register BMC Public Health 11 2011 450
20. M. Koster, K. Asplund, A. Johansson, and B. Stegmayr Refinement of Swedish administrative registers to monitor stroke events on the national level Neuroepidemiology 40 2013 240 246
21. K. Asplund, K. Hulter Asberg, and P. Appelros The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care Int J Stroke 6 2011 99 108
22. Riks-Stroke. Annual report 2012. Available at: http://www.riksstroke.org/wp-content/uploads/2014/02/Riks-Strokes-Arsrapport-2012.pdf. Accessed June 19, 2014.
23. P.C. Lavallee, E. Meseguer, and H. Abboud A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects Lancet Neurol 6 2007 953 960
24. M.H. Eckman, D.E. Singer, J. Rosand, and S.M. Greenberg Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation Circ Cardiovasc Qual Outcomes 4 2011 14 21
25. L. Friberg, L. Benson, M. Rosenqvist, and G.Y. Lip Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study BMJ 344 2012 e3522
26. J.B. Olesen, L. Fauchier, D.A. Lane, S. Taillandier, and G.Y. Lip Risk factors for stroke and thromboembolism in relation to age amongst patients with atrial fibrillation: the Loire Valley atrial fibrillation project Chest 141 2011 147 153
27. C.T. January, L.S. Wann, and J.S. Alpert 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 2014 e1 e76
28. A.K. Kakkar, I. Mueller, and J.P. Bassand International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD) Am Heart J 163 2012 13 19 e1
29. M.V. Huisman, G.Y. Lip, and H.C. Diener Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation Am Heart J 167 2014 329 334
30. J.Y. Le Heuzey, B. Ammentorp, and H. Darius Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry Thromb Haemostasis 111 2014 833 841
31. J.P. Piccini, E.S. Fraulo, and J.E. Ansell Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF Am Heart J 162 2011 606 612.e1
32. E. Ingelsson, J. Arnlov, J. Sundstrom, and L. Lind The validity of a diagnosis of heart failure in a hospital discharge register Eur J Heart Fail 7 2005 787 791